Researchers

Primary Investigator: Johanna Czamanski-Cohen, PhD

Johanna Czamanski-CohenPI Johanna Czamanski-Cohen is a lecturer in the School of Creative Art Therapies at the University of Haifa. Johanna is an art therapist with experience in adult Psychiatry, Psycho oncology and Women’s Health. Johanna’s research is focused on understanding the psychological and physiological effect of art-based interventions, the combination of CBT and Art Therapy and the role of emotion processing as a mechanism of salutary change.

Site Primary Investigators

Opher Caspi, MD PhD

Opher CaspiOpher Caspi site PI at Rabin Medical Center - This email address is being protected from spambots. You need JavaScript enabled to view it.

Dr. Caspi received his MD from the medical school of the Hebrew University and his PhD in Psychology from the University of Arizona. He is currently the Director of Integrative Medicine and Complementary Medicine Unit and the Dr. Israel (Roly) Rehabilitation Center at the Davidoff Center at the Davidoff Center, Beilinson Hospital, Rabin Medical Center. Dr. Caspi is certified in Internal Medicine and completed a fellowship in Integrative Medicine at the University of Arizona. He is also certified in Chinese Medicine from the Shandong College of Traditional Chinese Medicine and Hypnosis from the American Society of Clinical Hypnosis and Tel Aviv University. Dr. Caspi specializes in combining conventional and alternative / complementary treatment of cancer and internal diseases and decisions regarding recovery in complex clinical situations. Dr. Caspi is a member of the ethics committee of the Rabin Medical Center and is a member of the Complementary Medicine Society and the Israeli Medical Association. Dr. Caspi’s research is focused on decision-making and informed consent in integrative medicine; understanding the efficiency, safety, economic aspects, and ways of integrating complementary medicine into the health system; and evaluating the cost-benefit of cancer-recovery medicine from a social perspective.